CK Life Sciences Intl (Holdings) Inc
CIK: 0001297567
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DWTX
Dogwood Therapeutics, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
About CK Life Sciences Intl (Holdings) Inc
CK Life Sciences Intl (Holdings) Inc (SEC CIK 0001297567) files insider reports with the SEC as Director of Dogwood Therapeutics, Inc. (DWTX).
Signal8 holds 1 ownership filing by CK Life Sciences Intl (Holdings) Inc, a Form 4, filed on Mar 17, 2025. Those filings report 1 transaction, the latest on Mar 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on CK Life Sciences Intl (Holdings) Inc's filings is in NEW TERRITORIES, K3.
Recent filings by CK Life Sciences Intl (Holdings) Inc
- Mar 12, 2025: Grant or award of DWTX derivative securities (Form 4, code A).
Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)
- Sealbond Ltd, Director
- De La Rosa Abel, Director
- Thomas John C, Director
- Whitley Richard James, Director
- Keefer David R, Director
- Grosswald Ralph, SVP OF OPERATIONS